Trials / Completed
CompletedNCT05585931
Effect of TPN171H on Spermatogenesis
Evaluate the Acute Effects of a Single Oral Dose of TPN171H on Semen Function in Healthy Male Subjects in China
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Vigonvita Life Sciences · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This study is a phaseⅠstudy to determine the acute effects of TPN171H on semen function in healthy male subjects.
Detailed description
Safety Study in male subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TPN171H 10mg | Subjects were given 10mg TPN171H tablet with 240 mL warm water under fasting condition. |
| DRUG | TPN171H Placebo | Subjects were given Placebo with 240 mL warm water under fasting condition. |
Timeline
- Start date
- 2022-11-15
- Primary completion
- 2022-12-16
- Completion
- 2022-12-16
- First posted
- 2022-10-19
- Last updated
- 2023-02-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05585931. Inclusion in this directory is not an endorsement.